Default company panoramic image

VIDA Diagnostics

Clinically-validated quantitative pulmonary analysis software for early detection, evaluation in aiding of treatment of pulmonary disease.

  • Stage $1M in TTM Revenue
  • Industry Medical Devices and Equipment
  • Location Coralville, IA, USA
  • Currency USD
  • Founded January 2004
  • Employees 15
  • Website

Company Summary

VIDA Diagnostics is a leader in clinically-validated quantitative pulmonary analysis software for the early detection, evaluation and aiding of treatment of pulmonary disease including COPD, emphysema, lung cancer, and asthma. FDA approved and CE certified, VIDA's analysis methodology has been successfully tested in multiple academic, pulmonary device, and pharmaceutical clinical trials.


  • Default avatar
    Susan A. Wood, Ph.D.
    President and CEO

    Current President and CEO at VIDA Diagnostics, Inc.
    Former EVP, Marketing and Product Development, Vital Images, Inc.
    Former Vice President Marketing, R2 Technology, Inc.
    Former Director of Marketing at Cedara Software (formerly ISG)
    Ph.D., The Johns Hopkins University
    Masters, Biomedical Engineering, Duke University
    B.S. in Engineering, University of Maryland

Previous Investors

  • Default avatar
    First Iowa Capital Fund